Skip to main content

Table 1 CATHGEN and PREDICT microarray cohort clinical and demographic characteristics

From: Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients

  CATHGEN Microarray Cohort PREDICT Paired Microarray Cohort
  Controls Cases   Controls Cases  
Variable (N = 108) (N = 87) p.value (N = 99) (N = 99) p.value
Sex (%Male) 55 (50.9%) 58 (66.7%) 0.039 75(75.8%) 75 (75.8%) 0.868
Age (yrs) 55 ± 11 63 ± 10 <.001 55 ± 12 62 ± 11 <.001
Caucasian 56 (51.9%) 60 (69%) 0.023 85(85.9%) 92 (92.9%) 0.166
BMI 32 ± 7 30 ± 6 0.098 30 ± 7 30 ± 6 0.722
Current Smoker 41 (38%) 45 (51.7%) 0.075 14(14.1%) 25 (25.3%) 0.074
Systolic BP 144 ± 22 153 ± 25 0.007 132 ± 17 138 ± 18 0.009
Diastolic BP 83 ± 13 87 ± 15 0.077 82 ± 11 80 ± 12 0.271
Hypertension 67 (62%) 65 (74.7%) 0.084 55(55.6%) 65 (65.7%) 0.191
Dyslipidemia 55 (50.9%) 58 (66.7%) 0.039 50(50.5%) 69 (69.7%) 0.009
Neutrophil Count 3.8 ± 1.2 4 ± 1.3 0.392 3.9 ± 1.2 4.3 ± 1.5 0.037
Lymphocyte Count 1.8 ± 0.7 1.9 ± 0.7 0.87 2 ± 0.7 1.9 ± 0.6 0.239
  1. 1 Microarray cohort analyses are restricted to those whose arrays passed QC analysis (195/198 for CATHGEN and 198/210 for the PREDICT samples)